Lawson Euan, Khan Aqib, Wessels Quenton, Taylor Adam M
Lancaster Medical School, Lancaster University, Lancaster, UK
Lancaster Medical School, Lancaster University, Lancaster, UK.
BMJ Open. 2025 Jan 20;15(1):e088563. doi: 10.1136/bmjopen-2024-088563.
Congenital colour vision deficiency (CVD), known as colour blindness, is a common visual problem affecting around 1 in 12 men and 1 in 200 women. It is known that people who have red-green CVD, the most common phenotype, can have difficulty differentiating colours and this can impact the ability to perform clinical tasks related to patient care. The objective of this scoping review is to understand the extent and type of evidence and the impact on clinical practice and patient safety arising from congenital CVD in healthcare professionals.
The scoping review will follow the methodological framework outlined by the Joanna Briggs Institute and by Arksey and O'Malley and we will adhere to the Preferred Reporting Items for Systematic reviews and Meta-Analyses Scoping Reviews checklist. The following databases will be searched: PubMed, MEDLINE, Web of Science, Scopus, Lens.org and the Trip medical database (filtered for low-income countries) with no limit on earliest date and up to 30 November 2024. Grey literature will be identified by planned searches in the Overton Index. All articles related to 'CVD in healthcare professionals in clinical practice or in training' will be included. The study will also include other professionals who may be involved in healthcare but are not involved in direct patient-facing activities. It will be limited to congenital CVD and will exclude the impact of visual impairment and acquired CVD.There will be an initial search to validate the search strategy. Titles and abstracts will be screened to determine eligibility, and the full text will be reviewed using a data extraction framework. Data will be extracted, collated and then mapped and summarised to present the relevant key findings and outcomes from the papers in tabular and visualised form with a narrative synthesis.
The scoping review does not need ethical approval and will provide an overview of the impact of congenital CVD on clinical practice and patient safety. This will determine the future need and direction of research in this area and identify methodological challenges and opportunities. The results will be published open access in a peer-reviewed journal.
INPLASY (DOI: 10.37766/inplasy2024.11.0099).
先天性色觉缺陷（CVD），即色盲，是一种常见的视觉问题，影响着约十二分之一的男性和二百分之一的女性。众所周知，患有红绿色CVD（最常见的表型）的人在区分颜色方面可能存在困难，这可能会影响执行与患者护理相关的临床任务的能力。本范围综述的目的是了解先天性CVD在医疗保健专业人员中产生的证据的范围和类型，以及对临床实践和患者安全的影响。
本范围综述将遵循乔安娜·布里格斯研究所以及阿克西和奥马利概述的方法框架，并将遵循系统评价和Meta分析范围综述的首选报告项目清单。将搜索以下数据库：PubMed、MEDLINE、科学网、Scopus、Lens.org和Trip医学数据库（针对低收入国家进行筛选），对最早日期无限制，截止到2024年11月30日。灰色文献将通过在奥弗顿索引中进行计划搜索来识别。所有与“临床实践或培训中的医疗保健专业人员的CVD”相关的文章都将被纳入。该研究还将包括可能参与医疗保健但不参与直接面向患者活动的其他专业人员。研究将限于先天性CVD，并将排除视力损害和后天性CVD的影响。将进行初步搜索以验证搜索策略。将筛选标题和摘要以确定 eligibility，全文将使用数据提取框架进行审查。将提取、整理数据，然后进行映射和总结，以表格和可视化形式呈现论文的相关关键发现和结果，并进行叙述性综合。
本范围综述无需伦理批准，并将概述先天性CVD对临床实践和患者安全的影响。这将确定该领域未来的研究需求和方向，并识别方法学挑战和机遇。结果将在同行评审期刊上以开放获取的方式发表。
INPLASY（DOI：10.37766/inplasy2024.11.0099） 。 （注：原文中“eligibility”未翻译完整，推测可能是想说“筛选标题和摘要以确定是否符合纳入标准”之类意思，这里按原文呈现）
